Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A.

Tiede A, Allen G, Bauer A, Chowdary P, Collins P, Goldstein B, Jiang HJ, Kӧck K, Takács I, Timofeeva M, Wolfsegger M, Srivastava S.

Haemophilia. 2019 Nov 28. doi: 10.1111/hae.13878. [Epub ahead of print]

PMID:
31778283
2.

Deep infiltrating endometriosis: Can magnetic resonance imaging anticipate the need for colorectal surgeon intervention?

Brusic A, Esler S, Churilov L, Chowdary P, Sleeman M, Maher P, Yang N.

Eur J Radiol. 2019 Dec;121:108717. doi: 10.1016/j.ejrad.2019.108717. Epub 2019 Nov 6.

PMID:
31739271
3.

Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1).

Klamroth R, Feistritzer C, Friedrich U, Lentz SR, Reichwald K, Zak M, Chowdary P.

J Thromb Haemost. 2019 Oct 16. doi: 10.1111/jth.14660. [Epub ahead of print]

PMID:
31618804
4.

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P® /Humate P® treatment in von Willebrand disease patients.

de Jager NCB, Bukkems LH, Heijdra JM, Hazendonk CHCAM, Fijnvandraat K, Meijer K, Eikenboom J, Laros-van Gorkom BAP, Leebeek FWG, Cnossen MH, Mathôt RAA; OPTI-CLOT group.

J Thromb Haemost. 2019 Sep 26. doi: 10.1111/jth.14652. [Epub ahead of print]

PMID:
31557387
5.

A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia.

Benmassaoud A, AlRubaiy L, Yu D, Chowdary P, Sekhar M, Parikh P, Finkel J, See TC, O'Beirne J, Leithead JA, Patch D.

Aliment Pharmacol Ther. 2019 Nov;50(9):1049-1058. doi: 10.1111/apt.15479. Epub 2019 Sep 5.

PMID:
31489698
6.

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.

Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Chowdary P, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-Salek S, Oldenburg J.

Blood. 2019 Nov 28;134(22):1973-1982. doi: 10.1182/blood.2019001542.

PMID:
31444162
7.

Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A.

Chowdary P, Carcao M, Holme PA, Jiménez-Yuste V, Lentz SR, Møss J, Poulsen LH, Shen C, Tosetto A, Wheeler A, Santagostino E.

Res Pract Thromb Haemost. 2019 Jun 11;3(3):542-554. doi: 10.1002/rth2.12220. eCollection 2019 Jul.

8.

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.

Yu JK, Iorio A, Edginton AN; WAPPS co‐investigators.

Res Pract Thromb Haemost. 2019 May 20;3(3):528-541. doi: 10.1002/rth2.12204. eCollection 2019 Jul. Review. Erratum in: Res Pract Thromb Haemost. 2019 Sep 16;3(4):771.

9.

Vascular balloon occlusion and planned caesarean hysterectomy for morbidly adherent placenta: A systematic review.

Makary M, Chowdary P, Westgate JA.

Aust N Z J Obstet Gynaecol. 2019 Oct;59(5):608-615. doi: 10.1111/ajo.13027. Epub 2019 Jul 7. Review.

PMID:
31281966
10.

Prothrombin Complex Concentrates for Coagulopathy in Liver Disease: Single-Center, Clinical Experience in 105 Patients.

Drebes A, de Vos M, Gill S, Fosbury E, Mallett S, Burroughs A, Agarwal B, Patch D, Chowdary P.

Hepatol Commun. 2019 Feb 5;3(4):513-524. doi: 10.1002/hep4.1293. eCollection 2019 Apr.

11.

The use of new procoagulants in blunt and penetrating trauma.

Peralta MR, Chowdary P.

Curr Opin Anaesthesiol. 2019 Apr;32(2):200-205. doi: 10.1097/ACO.0000000000000696. Review.

PMID:
30817396
12.

The use of new procoagulants in blunt and penetrating trauma.

Peralta RM, Chowdary P.

Curr Opin Anaesthesiol. 2019 Jan 11. doi: 10.1097/ACO.0000000000000696. [Epub ahead of print]

PMID:
30640738
13.

The Role of the Mirena Intrauterine Device in the Management of Endometrial Polyps: A Pilot Study.

Chowdary P, Maher P, Ma T, Newman M, Ellett L, Readman E.

J Minim Invasive Gynecol. 2019 Nov - Dec;26(7):1297-1302. doi: 10.1016/j.jmig.2018.12.013. Epub 2018 Dec 24.

PMID:
30590128
14.

Multicentre retrospective study to assess diagnostic accuracy of ultrasound for superficial endometriosis-Are we any closer?

Chowdary P, Stone K, Ma T, Readman E, McIlwaine K, Druitt M, Ellett L, Cameron M, Maher P.

Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):279-284. doi: 10.1111/ajo.12911. Epub 2018 Nov 8.

PMID:
30411320
15.

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data.

Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Harder Delff P, Chowdary P.

Haemophilia. 2019 Jan;25(1):60-66. doi: 10.1111/hae.13627. Epub 2018 Nov 8.

PMID:
30408848
16.

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery.

Preijers T, Hazendonk HCAM, Liesner R, Chowdary P, Driessens MHE, Hart D, Keeling D, Laros-van Gorkom BAP, van der Meer FJM, Meijer K, Fijnvandraat K, Leebeek FWG, Collins PW, Cnossen MH, Mathôt RAA; OPTI‐CLOT study group.

J Thromb Haemost. 2018 Nov;16(11):2196-2207. doi: 10.1111/jth.14292. Epub 2018 Oct 28.

PMID:
30394056
17.

Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia.

Chowdary P.

Int J Hematol. 2018 Oct 9. doi: 10.1007/s12185-018-2548-6. [Epub ahead of print] Review.

PMID:
30302740
18.

Investigating the relationship between the HJHS and HAL in routine clinical practice: A retrospective review.

McLaughlin P, Morris R, Chowdary P.

Haemophilia. 2018 Nov;24(6):988-994. doi: 10.1111/hae.13614. Epub 2018 Oct 8.

PMID:
30295404
19.

Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.

Gruppo RA, Malan D, Kapocsi J, Nemes L, Hay CRM, Boggio L, Chowdary P, Tagariello G, von Drygalski A, Hua F, Scaramozza M, Arkin S; Marzeptacog alfa (activated) Study Group Investigators.

J Thromb Haemost. 2018 Oct;16(10):1984-1993. doi: 10.1111/jth.14247. Epub 2018 Aug 27.

PMID:
30151972
20.

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A.

Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Hyseni A, Friedrich U, Chowdary P.

J Thromb Haemost. 2018 Nov;16(11):2184-2195. doi: 10.1111/jth.14272. Epub 2018 Sep 30.

PMID:
30137664

Supplemental Content

Loading ...
Support Center